The National Centre for Pharmacoeconomics (NCPE) in Ireland are undertaking an assessment of Lutathera for approval in Ireland which is the first step to getting PRRT (Peptide receptor radionuclide therapy) here in Ireland.
[more information on PRRT below]
This is very important for Irish NET Patients, as having PRRT available in Ireland would mean Patients do not have to travel to another country to get it.
This survey was part of the NET Patient Day events on Saturday, but we want everyone included, so here is the link for anyone that has not already done the survey.
I made it so that it takes under 2 minutes to complete, so I hope you can please take the time to do it.
Thanks
More info on PRRT
https://www.cancercenter.com/treatment-options/precision-medicine/targeted-therapy/peptide-receptor-radionuclide-therapy
Related posts
Read more about events, news and relevant NETs information
- Assessment of Lutathera for PRRT, for approval in Ireland
The National Centre for Pharmacoeconomics (NCPE) in Ireland are undertaking an assessment of Lutathera for approval in Ireland which is the first step to getting PRRT … Read more - NET Patient Network Information Videos LaunchedNET Patient Network launched the first part of it’s major information initiative. Three new videos featuring experts in Nets care and patients with first-hand experience of … Read more
- New NETS information BookletsSaturday Nov 3rd, 2018, Devere Hall, University College, Cork The New NET Booklets from IPSEN are available to download in PDF format. We would like to … Read more
